Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression levels of serum mir-145-5p and Gas6 in women with early-onset preeclampsia and their clinical significance. | Cell Mol Biol (Noisy-le-grand) | 2022 | 35809311 | PubTator, text mining | PubMed |
| Editorial for the Special Issue "Vitamin K in Chronic Disease and Human Health". | Nutrients | 2022 | 35807776 | PubTator, text mining | PubMed |
| Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity? | Int J Mol Sci | 2022 | 35806251 | PubTator, text mining | PubMed |
| Immunorthodontics: Role of HIF-1α in the Regulation of (Peptidoglycan-Induced) PD-L1 Expression in Cementoblasts under Compressive Force. | Int J Mol Sci | 2022 | 35805974 | PubTator, text mining | PubMed |
| Integrin β3 Promotes Resistance to EGFR-TKI in Non-Small-Cell Lung Cancer by Upregulating AXL through the YAP Pathway. | Cells | 2022 | 35805163 | PubTator, text mining | PubMed |
| Circular dorsal ruffles disturb the growth factor-induced PI3K-AKT pathway in hepatocellular carcinoma Hep3B cells. | Cell Commun Signal | 2022 | 35799301 | PubTator, text mining | PubMed |
| Suppression of heparan sulfation re-sensitizes YAP1-driven melanoma to MAPK pathway inhibitors. | Oncogene | 2022 | 35798875 | PubTator, text mining | PubMed |
| Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo. | Ren Fail | 2022 | 35793478 | PubTator, text mining | PubMed |
| T Lymphocytes as Targets for SARS-CoV-2. | Biochemistry (Mosc) | 2022 | 35790412 | PubTator, text mining | PubMed |
| Characterization of extracellular vesicles isolated from different liquid biopsies of uveal melanoma patients. | J Circ Biomark | 2022 | 35784590 | PubTator, text mining | PubMed |
| Human Testicular Germ Cells, a Reservoir for Zika Virus, Lack Antiviral Response Upon Zika or Poly(I:C) Exposure. | Front Immunol | 2022 | 35784373 | PubTator, text mining | PubMed |
| Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine. | Genes Dis | 2022 | 35782973 | PubTator, text mining | PubMed |
| Comprehensive analysis of the novel omicron receptor AXL in cancers. | Comput Struct Biotechnol J | 2022 | 35782741 | PubTator, text mining | PubMed |
| Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis. | Front Pharmacol | 2022 | 35774616 | PubTator, text mining | PubMed |
| Molecular Pathways and Roles for Vitamin K2-7 as a Health-Beneficial Nutraceutical: Challenges and Opportunities. | Front Pharmacol | 2022 | 35774605 | PubTator, text mining | PubMed |
| Regulation and dysregulation of hair regeneration: aiming for clinical application. | Cell Regen | 2022 | 35773427 | PubTator, text mining | PubMed |
| The impact of warfarin on overall survival in cancer patients. | Thromb Res | 2022 | 35769870 | PubTator, text mining | PubMed |
| MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity In Vitro, In Vivo, and Ex Vivo. | Antimicrob Agents Chemother | 2022 | 35766508 | PubTator, text mining | PubMed |
| Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma. | Oncology | 2022 | 35760058 | PubTator, text mining | PubMed |
| Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells. | Front Cell Dev Biol | 2022 | 35756991 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=46